eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 10/05/2011
PIL Relenza 5mg/dose inhalation powder (Print friendly)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects
Updated on 19/08/2010 and displayed until 10/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 13/11/2009 and displayed until 19/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/11/2009 and displayed until 13/11/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/10/2009 and displayed until 02/11/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 07/05/2009 and displayed until 26/10/2009
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  zanamivir